The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

NCT06112041 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma
Solid Tumor

Interventions

DRUG: ADC Combined With Radiotherapy, PD-L1 Sequential GM-CSF and Thymopentin

Sponsor

Second Affiliated Hospital of Soochow University